Liru Q. He

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Corrigendum to "Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma" [Radiother. Oncol. 206 (2025) 110802].

Corrigendum to "Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma" [Radiother. Oncol. 206 (2025) 110802].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 09, 2026

Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trial.

Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trial.

Journal: BMC medicine

Published: November 21, 2025

Auto-Segmentation and Auto-Planning in Automated Radiotherapy for Prostate Cancer.

Auto-Segmentation and Auto-Planning in Automated Radiotherapy for Prostate Cancer.

Journal: Bioengineering (Basel, Switzerland)

Published: April 28, 2025

Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma.

Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 22, 2024

Impact of bladder volume and bladder shape on radiotherapy consistency and treatment interruption in prostate cancer patients.

Impact of bladder volume and bladder shape on radiotherapy consistency and treatment interruption in prostate cancer patients.

Journal: Journal of applied clinical medical physics

Published: October 08, 2024

Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?

Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?

Journal: Translational andrology and urology

Published: September 13, 2024

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Journal: Clinical genitourinary cancer

Published: September 01, 2023

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Journal: Therapeutic advances in medical oncology

Published: July 11, 2023

The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma.

The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma.

Journal: Clinical epigenetics

Published: July 20, 2022

Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 21, 2022

Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities.

Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities.

Journal: Cancer medicine

Published: February 04, 2022

Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.

Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.

Journal: International journal of cancer

Published: December 28, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026